Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica

J Rheumatol. 2021 Sep 15:jrheum.210455. doi: 10.3899/jrheum.210455. Online ahead of print.ABSTRACTGlucocorticoids (GCs) are the mainstay of treatment for patients with polymyalgia rheumatica (PMR).1 Despite their efficacy, GCs are associated with well-known adverse events and a substantial proportion of patients with PMR do not respond adequately, or are refractory, to initial GC treatment. GC-sparing agents in PMR are limited to methotrexate (MTX).1.PMID:34526393 | DOI:10.3899/jrheum.210455
Source: Journal of Rheumatology - Category: Rheumatology Authors: Source Type: research